Best Lawyers for Pharmaceuticals Law in Munich, Germany

Search Best Lawyers Now

*This search returned more than the maximum results. Please refine your search using the links above.
Lawyer
  • Recognized Since: 2021
  • Location:
    Munich, Germany
  • Practice Areas:
    Intellectual Property Law Pharmaceuticals Law
Lawyer
  • Recognized Since: 2021
  • Location:
    Munich, Germany
  • Practice Areas:
    Pharmaceuticals Law Litigation
Lawyer
  • Recognized Since: 2018
  • Location:
    Munich, Germany
  • Practice Areas:
    Advertising Law Pharmaceuticals Law Litigation
Lawyer
  • Recognized Since: 2021
  • Location:
    Munich, Germany
  • Practice Areas:
    Health Care Law Pharmaceuticals Law
Lawyer
  • Recognized Since: 2018
  • Location:
    Munich, Germany
  • Practice Areas:
    Intellectual Property Law Pharmaceuticals Law
Lawyer
  • Recognized Since: 2018
  • Location:
    Munich, Germany
  • Practice Areas:
    Health Care Law Pharmaceuticals Law Biotechnology Law and Life Sciences Practice Mergers and Acquisitions Law
Lawyer
  • Recognized Since: 2017
  • Location:
    Munich, Germany
  • Practice Areas:
    Health Care Law Litigation Pharmaceuticals Law Advertising Law
Lawyer
  • Recognized Since: 2021
  • Location:
    Munich, Germany
  • Practice Areas:
    Pharmaceuticals Law

  • Recognized Since: Ones to Watch Since:
  • Location:
  • Practice Areas:

Recognition by Best Lawyers is based entirely on peer review. Our methodology is designed to capture, as accurately as possible, the consensus opinion of leading lawyers about the professional abilities of their colleagues within the same geographical area and legal practice area.

Best Lawyers employs a sophisticated, conscientious, rational, and transparent survey process designed to elicit meaningful and substantive evaluations of the quality of legal services. Our belief has always been that the quality of a peer review survey is directly related to the quality of the voters.

Practice Area Definition

Pharmaceuticals Law Definition

Life Sciences is one of the most innovative, fast-changing, and complex market sectors. It is also one of the most regulated. Currently pharmaceutical and medical device companies face increased examination from regulators and increasing pricing pressure. The industry is undergoing a period of intense transformation, with companies facing an ever-increasing level of strict cost management in order to remain competitive and profitable. Whereas the rules and regulations with regard to pharmaceuticals, medical devices, other health care products, food, and food supplements are largely harmonised throughout the EU this is not the case for the full set of the legal framework relevant for the market access of these products

Law firms which are active in the life sciences sector have to provide a comprehensive legal service to multinational and local pharmaceutical, listed biotech and medical device companies. Furthermore, they support venture capital backed start-up companies as well as service providers. The advice of law firms specialised in this area usually extends to the full range of practice areas that are central to the business of life sciences companies throughout the clients’ whole product life cycle, from discovery and development of the drug through to end-of-life patent disputes. For instance, their services include legal consulting in regard to licensing and collaboration, product liability, intellectual property, trademarks, manufacturing and distribution agreements, corporate transactions (mergers and acquisitions, joint ventures, private equity, venture capital), regulatory issues, competition (anti-trust), as well as state-aid law and subsidies.

In regard to regulatory law, clients of legal services providers in the life sciences sector frequently demand support in regard to clinical trial regulation, data and market exclusivity, supplementary protection certificates (SPC), and paediatric regulation. In addition, lawyers help them with issues concerning orphan drug designation, marketing authorization procedures, promotion campaigns and compliance issues, as well as pricing, reimbursement, and market access. Furthermore, they also provide their services in regard to more complex products of the industry such as biosimilars and personalized medicines. As the legislative and regulatory framework differs from one jurisdiction to another both local and international specialist knowledge is required to provide comprehensive regulatory law services in the life sciences sector.

Taylor Wessing Partnerschaftsgesellschaft mbB

Taylor Wessing Partnerschaftsgesellschaft mbB logo

Life Sciences is one of the most innovative, fast-changing, and complex market sectors. It is also one of the most regulated. Currently pharmaceutical and medical device companies face increased examination from regulators and increasing pricing pressure. The industry is undergoing a period of intense transformation, with companies facing an ever-increasing level of strict cost management in order to remain competitive and profitable. Whereas the rules and regulations with regard to pharmaceuticals, medical devices, other health care products, food, and food supplements are largely harmonised throughout the EU this is not the case for the full set of the legal framework relevant for the market access of these products

Law firms which are active in the life sciences sector have to provide a comprehensive legal service to multinational and local pharmaceutical, listed biotech and medical device companies. Furthermore, they support venture capital backed start-up companies as well as service providers. The advice of law firms specialised in this area usually extends to the full range of practice areas that are central to the business of life sciences companies throughout the clients’ whole product life cycle, from discovery and development of the drug through to end-of-life patent disputes. For instance, their services include legal consulting in regard to licensing and collaboration, product liability, intellectual property, trademarks, manufacturing and distribution agreements, corporate transactions (mergers and acquisitions, joint ventures, private equity, venture capital), regulatory issues, competition (anti-trust), as well as state-aid law and subsidies.

In regard to regulatory law, clients of legal services providers in the life sciences sector frequently demand support in regard to clinical trial regulation, data and market exclusivity, supplementary protection certificates (SPC), and paediatric regulation. In addition, lawyers help them with issues concerning orphan drug designation, marketing authorization procedures, promotion campaigns and compliance issues, as well as pricing, reimbursement, and market access. Furthermore, they also provide their services in regard to more complex products of the industry such as biosimilars and personalized medicines. As the legislative and regulatory framework differs from one jurisdiction to another both local and international specialist knowledge is required to provide comprehensive regulatory law services in the life sciences sector.